Correlation Between Effector Therapeutics and Altamira Therapeutics
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Altamira Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Altamira Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Altamira Therapeutics, you can compare the effects of market volatilities on Effector Therapeutics and Altamira Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Altamira Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Altamira Therapeutics.
Diversification Opportunities for Effector Therapeutics and Altamira Therapeutics
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Effector and Altamira is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Altamira Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altamira Therapeutics and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Altamira Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altamira Therapeutics has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Altamira Therapeutics go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Altamira Therapeutics
Given the investment horizon of 90 days Effector Therapeutics is expected to under-perform the Altamira Therapeutics. In addition to that, Effector Therapeutics is 3.47 times more volatile than Altamira Therapeutics. It trades about -0.4 of its total potential returns per unit of risk. Altamira Therapeutics is currently generating about -0.2 per unit of volatility. If you would invest 161.00 in Altamira Therapeutics on August 26, 2024 and sell it today you would lose (119.00) from holding Altamira Therapeutics or give up 73.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 21.26% |
| Values | Daily Returns |
Effector Therapeutics vs. Altamira Therapeutics
Performance |
| Timeline |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Altamira Therapeutics |
Effector Therapeutics and Altamira Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Effector Therapeutics and Altamira Therapeutics
The main advantage of trading using opposite Effector Therapeutics and Altamira Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Altamira Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altamira Therapeutics will offset losses from the drop in Altamira Therapeutics' long position.| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
| Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |